Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Morokoff

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|November 30, 2016
Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatinIwan E Bennett, Kathryn M Field, Christopher M Hovens, et al.
Translational Oncology|September 17, 2018
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved DrugsClarissa A Whitehead, Hong P T Nguyen, Andrew P Morokoff, et al.
Epilepsia|March 28, 2024
Amygdala enlargement in temporal lobe epilepsy: Histopathology and surgical outcomesLubna Shakhatreh, Ben Sinclair, Catriona McLean, et al.
Molecular Immunology|January 26, 2024
Signaling pathways underlying TGF-β mediated suppression of IL-12A gene expression in monocytesTetiana Hourani, Mahtab Eivazitork, Thivya Balendran, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2015
Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiformeIwan E Bennett, Hui Guo, Nicole Kountouri, et al.
Brain Sciences|January 22, 2024
Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and InvasionSarah F Stuart, Peter Curpen, Adele J Gomes, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
Neuro-Oncology Advances|April 4, 2024
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in gliomaJordan J Jones, Hong Nguyen, Stephen Q Wong, et al.
Medical Oncology (Northwood, London, England)|April 22, 2016
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomibZammam Areeb, Stanley S Stylli, Thomas M B Ware, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|November 30, 2016
Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatinIwan E Bennett, Kathryn M Field, Christopher M Hovens, et al.
Translational Oncology|September 17, 2018
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved DrugsClarissa A Whitehead, Hong P T Nguyen, Andrew P Morokoff, et al.
Epilepsia|March 28, 2024
Amygdala enlargement in temporal lobe epilepsy: Histopathology and surgical outcomesLubna Shakhatreh, Ben Sinclair, Catriona McLean, et al.
Molecular Immunology|January 26, 2024
Signaling pathways underlying TGF-β mediated suppression of IL-12A gene expression in monocytesTetiana Hourani, Mahtab Eivazitork, Thivya Balendran, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2015
Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiformeIwan E Bennett, Hui Guo, Nicole Kountouri, et al.
Brain Sciences|January 22, 2024
Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and InvasionSarah F Stuart, Peter Curpen, Adele J Gomes, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
Neuro-Oncology Advances|April 4, 2024
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in gliomaJordan J Jones, Hong Nguyen, Stephen Q Wong, et al.
Medical Oncology (Northwood, London, England)|April 22, 2016
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomibZammam Areeb, Stanley S Stylli, Thomas M B Ware, et al.
Pageof 5